INTROduCTION
Plasmacytoid dendritic cells (pDCs) constitute a separate subset within the DC lineage and have been shown to exert both immunostimulatory and immunosuppressive functions. PDCs express the Toll like receptors (TLR)-7 and TLR9, 1 which upon sensing viral RNA or bacterial DNA, respectively, are able to produce large amounts of the type I Interferons (IFN)-α and IFN-β. 2 These are pleiotropic cytokines that can activate multiple arms of the immune system, including T cells, B cells, NK cells, and conventional (c)-DCs, 3 and also have a direct anti-replicative effect on the virus. 4 Further, TLR triggering induces secretion of additional cytokines such as IL-6 and TNF-α that mediate maturation of pDCs into antigen presenting cells (APCs) that can prime both CD4 and CD8 T cell responses. 5 Conversely, pDCs have been implicated in dampening of immune responses.
TLR7/9 engagement induces expression of the immunosuppressive enzyme indoleamine-2,3-dioxygenase (IDO), which degrades the essential amino acid tryptophan, thereby suppressing T cell responses. 6 In addition, pDCs constitutively express the serine protease granzyme B (GrB), 7, 8 which is upregulated and secreted in response to IL-3, either alone or in combination with IL-10.
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PDC-derived GrB is active, as it was shown in cytotoxicity experiments using the erythroleukemic cell line K562. 7 In addition, it yields suppression of T cell proliferation in a perforin-independent manner, although the mechanism underlying this effect remained elusive. 9 Following activation and polarization of T cells by APCs, T cells produce cytokines that impact on the immune response. In a classical division, T helper (Th)-1 cells produce IFN-γ, while IL-4, IL-5 and IL-13 are the signature cytokines produced by Th2 cells. 10 In addition, other
Th subsets have been defined, including Th17 cells, which predominantly make IL-17. 11 Another cytokine that more recently attracted attention is IL-21, which is a member of the common γ-chain family of cytokines, to which IL-2, IL-4, IL-7, IL-9, and IL-15 belong as well. 12, 13 Production of IL-21 was originally documented to be restricted to CD4 + T cells in particular to T-follicular helper cells found in or near the B-cell areas of secondary lymphoid tissue. In mice it is clear that IL-21 is produced also by other types of T cells, including Th17 cells and natural killer T (NKT) cells. 14 The functional receptor for IL-21 exists as a heterodimer that comprises the IL-21R and the common γ chain (γc; CD132). 15 In the absence of the γc, IL-21 can bind the IL-21R, but does not transduce intracellular signaling. Expression of the IL-21R complex is detected in lymphoid tissues, including spleen, thymus, and peripheral blood cells, indicating that IL-21 has regulatory functions on many cell types. While the IL-21R is shown to be expressed on resting and activated B cells, T cells, NK cells, dendritic cells (DCs), macrophages and keratinocytes, 16, 17 it has remained elusive whether pDCs express this cytokine receptor.
Here we have investigated the role of IL-21 on the phenotype and function of human pDCs. We observed that pDCs expressed a functional IL-21R as STAT3 was rapidly phosphorylated in response to IL-21. IL-21 did not impact on TLR-induced production of type I IFNs, IL-6 or TNF-α by pDCs. IL-21 also did not interfere with TLR induced maturation of pDCs, since expression of costimulatory molecules, such as CD40, CD80 and CD86, and MHC molecules were upregulated to a similar level either in the absence or presence of IL-21. Notably, we observed that IL-21 induced the expression and secretion of GrB in pDCs. Moreover, GrB secreted from TLR/IL-21 four pre-activated pDCs inhibited proliferation of T cells. Our findings demonstrate a novel role for IL-21 to control pDCs. We hypothesize that activated T cells in a negative feedback loop may be controlled by pDCs through production of GrB, which impairs the expansion of the T cell pool.
MATERIAL ANd METhOdS human pdC, T and B cell isolations
Peripheral blood of healthy volunteers was used for isolation of pDCs upon donor consent (Sanquin Bloodbank, Amsterdam, The Netherlands). Postnatal thymus tissue was obtained from surgical specimens removed from children up to 3 years of age undergoing open heart surgery (LUMC, Leiden, The Netherlands). Tonsils were obtained from routine tonsillectomies (department of Otolaryngology, AMC, Amsterdam, The Netherlands). Use of these tissues was approved by the medical ethical committee of the AMC. Thymocytes and lymphocytes from peripheral blood and from tonsils were isolated from a Ficoll-Hypaque density gradient (Lymphoprep; Nycomed Pharma, Oslo, Norway). Subsequently, BDCA4 + cells were enriched by immunomagnetic bead selection, using the BDCA4 cell separation kit (Miltenyi Biotec, Bergisch Gladbach, Germany). CD123 + CD45RA + pDCs were sorted by flow cytometry on a FACSAria (BD Biosciences). Peripheral blood T cells and B cells were enriched using the CD3 and CD19 cell selection kits (Miltenyi Biotec), respectively, and sorted using anti-CD3 and anti-CD19 antibodies. Purity was ≥ 99% and confirmed by reanalysis of sorted cells.
Reagents for functional assay
To test activation and maturation of pDCs, cells were cultured in Yssel's medium, 18 supplemented with 2% human serum (Invitrogen). Oligodeoxynucleotides CpG-A (ODN2216) and CpG-B (ODN2006), and R848 were purchased from Invivogen. Mouse Recombinant IL-21 was obtained from R&D Systems, and is cross-reactive between mouse and human. The Z-AAD-CMK specific inhibitor of GrB was purchased from Enzo Life Sciences (NY, USA). Recombinant GrB (SigmaAldrich (St Louis, MO, USA) was used at 10 or 100 ng/mL. Recombinant IFN-α (Roferon-A; Hoffmann La Roche, Basel, Switzerland) was used at 1000 U/mL.
Flow cytometry
For flow cytometric analysis, single cell suspensions were stained with fluorescein isothiocyanate (FITC), phycoerythrin (PE), PE-Cy7, allophycocyanin (APC), APC-Cy7, or Peridinin chlorophyll (PerCP) coupled anti-human monoclonal antibodies (Abs) targeting the following cell surface markers: CCR7, CD40, CD45RA, CD80, CD86, CD123, HLA-DR, CD3, CD11c, CD14, CD19, CD56, or isotype controls (BD Bioscience), and BDCA2 (Miltenyi Biotech). Human IL-21R was detected on the cell surface using an APC-mouse-anti-human-IL-21R Ab (R&D systems). 
ELISA and CBA assays
PDCs were activated overnight with CpG-A (10 µg/mL), CpG-B (10 µg/mL) or R848 (10 µg/mL), in the presence or absence of recombinant mouse IL-21 (25 ng/mL). Cell-free culture supernatants were collected and analyzed for the presence of cytokines IL-6 and TNF-α using ELISA (IL-6, U-CyTech biosciences, Utrecht, The Netherlands; TNF-α, eBioseciences, CA, USA), or using the Cytometric Bead Array (CBA), according to the manufacturer's protocol (CBA Human Inflammation kit, BD Biosciences). GrB present in the culture medium was quantified using the PeliKine Compact human Granzyme B ELISA kit (M1936, Sanquin), according to the manufacturers protocol.
PCR
For PCRs, total RNA was extracted using Trizol reagent (Invitrogen). RNA concentration and quality was determined using the Nanodrop spectrophotometer (Thermo Fisher Scientific). Equal amounts of total RNA were reverse transcribed into cDNA using the RNA-to-cDNA kit (Roche) according to the manufacturer's instructions. cDNA was amplified using a PCR machine for conventional RT-PCR and separated on a 1.5% agarose gel, or amplified using an iCycler and SYBRgreen supermix (BioRad) for quantitative PCR (QPCR) using specific primer sets (supplementary table 1). Each sample was analyzed in triplicates and expression levels were normalized to the three housekeeping genes β-Actin, GAPDH and HPRT.
Allogeneic T cell stimulation
Lymphocytes from peripheral blood were isolated by Ficoll gradient centrifugation as described in the "human pDC isolation" section. CD4 + T cells were sorted as lineage (CD11c
) negative cells using a FACS ARIA (BD Biosciences). Sorted pDCs from peripheral blood were incubated with or without the TLR7 ligand R848 for 48h in the absence or presence of IL-21 (25ng/ mL). Subsequently, pDCs were co-cultured with T cells at a 1:5 ratio for 6 days in Yssel's medium 18 supplemented with 2% human serum. Cell proliferation was assessed using the CellTrace-violet proliferation kit (Invitrogen) according to the manufacturer's instructions. T cells activated with human T-expander CD3/CD28 beads (Dynabeads, Dynal, Invitrogen) were used as a positive control.
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Statistical analyses
Data were subjected to two-tailed paired Student's t-test analysis using Graphpad Prism 5 for Windows (Graphpad software, San Diego, USA) and considered significant when at least P < 0.05.
RESuLTS pdCs express a functional IL-21R
The IL-21R was shown to be expressed by several immune cell types, including B cells and T cells. 19 Evidence that pDCs express this receptor is lacking. We therefore analyzed human pDCs from 2 independent donors for expression of the IL-21R transcript by RT-PCR ( Figure 1A ) and compared expression to that in primary B cells (CD19 MACS-enriched) and T cells (CD3 MACS-enriched or sorted total CD4 + T cells). We observed that pDCs, B cells, and T cells all expressed the IL-21RA
chain. Furthermore, protein expression of the IL-21Rα chain was detected by flow cytometry at the cell surface of freshly isolated pDCs from peripheral blood, thymus and tonsil ( Figure 1B and data not shown). The expression level of the IL-21R on peripheral blood pDCs was comparable to the levels detected on T and B cells and other (non-pDC/T/B) cells from the same donor ( Figure  1B ). To further characterize whether the IL-21R expressed on pDCs was functional, we stimulated human pDCs from blood, thymus and tonsils with IL-21 and evaluated the phosphorylation of STAT3, which is a key component of the IL-21R downstream signalling pathway. 19 As shown by flow cytometric analysis, IL-21 upregulated pSTAT3 levels as compared to unstimulated cells independent of their source of origin ( Figure 1C ). pSTAT3 levels in unstimulated tonsil pDCs appear increased compared to thymus and blood pDCs, which may suggest that STAT3 is constitutively activated in tonsil pDCs. While this may reflect the inflamed condition of tonsil, it may well be independent of IL-21. IL-21 did not phosphorylate STAT1 in pDCs (Suppl. Figure 1A ) in contrast to IFN-α (Suppl. Figure 1B ). Increased levels of pSTAT5 in response to IL-21 could only be observed in pDCs isolated from blood, but not thymus or tonsil, although the results may suggest that STAT5 may be constitutively activated in thymus and tonsil pDCs (Suppl. Figure 1 ). Taken together, these data show that human pDCs not only express the IL-21R chain, but in addition that the receptor is functional when engaged by its physiological ligand.
IL-21 does not affect pdC survival and cytokine production
To unravel the putative role of the IL-21R on pDCs, we first investigated the effect of IL-21 on pDC survival, both in the presence and absence of TLR stimulation. We observed no significant differences of IL-21 on cell survival after 4 days, neither in TLR unstimulated cells, nor after stimulation with the TLR7 ligand R848, as shown by apoptosis staining using AnnexinV and 7-AAD ( 
IL-21 does not interfere with TLR-induced maturation of pdCs
Engagement of TLR induces differentiation of pDCs into mature DCs that have upregulated expression levels of MHC-II, chemokine receptor CCR7, and co-stimulatory molecules, including CD40, CD80, and CD86. 3 We were interested to analyze whether IL-21 affects this process. We observed that the maturation of pDCs from blood, tonsil or thymus upon CpG-B or R848 stimulation was not changed by IL-21, as equal levels of the co-stimulatory molecules CD40, CD80, CD86 were detected by flow cytometry both after 1 and 2 days of stimulation (Figure 3 , Suppl. Fig. 2 and 3, and data not shown) . Similarly, no effect of IL-21 on expression of HLA-DR and CCR7 was observed. Taken together, these results indicate that IL-21 does not interfere with the TLR induced functionality of pDCs in terms of activation and maturation.
IL-21 induces grB expression in pdCs and is modulated by TLR stimulation
PDCs, unlike conventional DCs, constitutively express GrB, although conflicting data have been reported in literature. [7] [8] [9] To further elucidate this and to address whether IL-21 affects
GrB expression, we cultured pDCs in the presence or absence of IL-21. We confirmed earlier observations 7, 8 that freshly isolated pDCs constitutively express GrB independent of their source of origin (tonsil, thymus, peripheral blood) ( Figure 4A ). Notably, IL-21 had a major impact on GrB levels in pDCs as IL-21 induced GrB expression both at the transcriptional ( Figure 4B ) and at the protein ( Figure 4C ) level. Already 4h after stimulation of pDCs, IL-21 induced the level of GrB mRNA 3.2-fold as measured by QPCR analysis, while after 6h this was even higher 7.5-fold as compared to medium cultured pDCs ( Figure 4B ). Secretion of active GrB from pDCs (tonsil, n = 5; blood, n = 2) was measured in the supernatant after culture in the presence or absence of IL-21 in serum-free medium for 16h by ELISA ( Figure 4C ). In all donors, IL-21 induced higher levels of GrB in pDCs as compared to medium cultured cells. Tonsil pDCs secreted 2.5-fold more GrB in response to IL-21 (515+/-195 pg/mL; p < 0.05) compared to medium (209+/-134 pg/mL). Blood pDCs secreted 2.3-fold higher GrB levels in response to IL-21 (566+/-261 pg/mL) compared to medium (245+/-205 pg/mL). Notably, low levels of GrB could be detected when cells were cultured in the absence of IL-21, and is in line with our findings that pDCs constitutively express GrB ( Figure 4C ). To investigate the effect of IL-21 on GrB production upon pDC activation, ex vivo pDCs from tonsil or blood were stimulated with the TLR9 agonist CpG-B or with the TLR7 agonist R848 in the presence or absence of IL-21. After overnight or 2 days of stimulation, GrB expression was assessed by flow cytometry after intracellular staining ( Figure 4D-E) . We observed that stimulation of pDCs with either CpG-B or R848 reduced GrB levels as compared to medium cultured pDCs. This is in contrast to pDCs incubated with IL-21 alone in the absence of TLR ligands, where GrB expression increased as compared to the medium control cultured pDCs. Notably, TLR-induced GrB inhibition in the concomitant presence of IL-21 was only partial. In this condition, GrB levels were comparable to the levels that were expressed in medium cultured cells (Figure 4D-E) . The effect of IL-21 on the GrB levels in R848 stimulated blood pDCs for 2 days was comparable to overnight stimulation, although less pronounced ( Figure 4E) . Analysis of the secreted levels of GrB in the supernatant of overnight cultured pDCs (Suppl. these results show that pDCs constitutively express and secrete GrB and that IL-21 potently induces GrB expression, which can be partially antagonized by TLR co-ligation.
IL-21-induced grB production by pdCs inhibits T cell proliferation
During a viral or bacterial infection, CD4 + T cells and NKT cells are the main producers of IL-21.
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To investigate the role of IL-21 in the interactions between pDCs and T cells during an immune four IL-21 controLs pDc functIon by InDuctIon of Grb response, we performed in vitro allogeneic T cell stimulation assays using pre-activated pDCs. First, pDCs were activated with the TLR7 ligand R848, or with the TLR9 ligand CpG-B, in the presence or absence of IL-21 for 48h ( Figure 5 and data not shown). After extensive washing, pre-activated pDCs were co-cultured with resting allogeneic CD4 + T cells for 6 days. T cell proliferation was assessed by measuring the loss of the dye CellTrace-violet upon cell division using flow cytometry. In addition, we included 7-AAD in our analyses to measure cell death. Both TLR7 as well as TLR9 activated pDCs were able to induce T cell proliferation ( Figure 5A and data not shown). Allogeneic T cell proliferation induced by activated pDCs was lower than that induced by polyclonal stimulation using anti-CD3/CD28 beads. IL-21 pre-activated pDCs did not induce the proliferation of T cells as compared to medium cultured pDCs. Notably, when pDCs were pre-activated by the TLR agonists in the presence of IL-21 they were less capable to induce T cell proliferation as compared to TLR-activated pDCs in the absence of IL-21 (R848: 40% versus R848+IL-21: 15%). This decrease in the percentage of expanded T cells was not due to increased cell death, since the percentage of 7-AAD + T cells were similar in both conditions ( Figure 5A ). To demonstrate that GrB could be involved in blocking T cell proliferation we added a GrB inhibitor during the pDC-T cell co-culture. Indeed, T cell proliferation was restored at least in part by impairing the activity of GrB. In all conditions statistically significant differences were observed when analyzing multiple donors (n = 4) ( Figure 5B ). Culture of CD4 + T cells in the presence of recombinant GrB did not affect proliferation (Suppl. Figure 5 ). Hence, our data support the notion that GrB, which is increased in pDCs upon stimulation with IL-21, affects the level of T cell proliferation induced by TLR-activated pDCs in a cell contact dependent manner.
dISCuSSION
To our knowledge, this study is the first to show constitutive expression of the IL-21R on human pDCs. We show that the IL-21R is functionally expressed, since IL-21 stimulation of pDCs resulted in activation of the downstream signaling molecule STAT3. IL-21 by itself did not affect pDC activation nor maturation or cytokine production in response to TLR ligation. However, IL-21 induced GrB expression in pDCs. Moreover, we demonstrate that IL-21-induced GrB was secreted by pDCs, which contributes to impairing CD4 + T cell proliferation in an allogeneic setting.
Despite the pleiotropic effect of IL-21 on a wide range of immune cells, its role on pDCs has previously not been investigated. In mice, bone marrow-derived conventional DCs (BMDCs) generated in the presence of IL-21 (IL-21-DCs) showed an impaired activation and maturation capacity. 20 Consistent with this, IL-21 pretreated BMDCs when adoptively transferred failed to induce T cell activation in vivo. 21 Human monocyte-derived DCs pretreated with IL-21 also failed to upregulate CD86 and MHCII expression in response to LPS, although the consequence of this with respect to T cell stimulatory capacity was not analyzed. 22 In our studies using human pDCs, we did not observe significant differences in expression of maturation markers, including CD40, CD80, CD86, MHCII, or CCR7, in response to TLR agonists either in the presence or absence of IL-21. Therefore, this cannot explain the impaired T cell proliferation we observed in the presence of TLR/IL-21 stimulated pDCs as compared to TLR only stimulated pDCs. Moreover, impaired ability of TLR/IL21-pDCs to activate T cells cannot be due to increased apoptosis induction of the pDCs themselves, since IL-21 did not affect pDCs survival. Increased apoptosis induction of T cells was not observed either, hence it is more likely that GrB secreted by IL-21 stimulated pDCs hampered T cell proliferation. This is underscored by our finding that addition of a GrB inhibitor partially restored T cell expansion. It is generally accepted that differentiation, expansion and survival of T cells is enforced in response to cues delivered by DCs. While antigen presentation is key to DCs functioning, additional signals will polarize T cells to induce a tailored immune response against microbial infections. In return, T cell responses should be downmodulated in order to avoid overactivation of the immune system. In physiological conditions, activated T cells and pDCs may meet in the lymph node where follicular helper CD4 + T (Tfh) cells produce its primary cytokine IL-21, which provide B cells with signals that are important for the generation of high-affinity antibodies and immunological memory. 23 It is reasonable to assume that IL-21 reversely may serve to dampen Tfh responses through induction of GrB in pDCs and thereby help to return to homeostasis at the stage where antibodies have been formed and there is resolution of infection. Previously, GrB was shown to enter T cells and via an as yet unknown mechanism to impair proliferation. 9 A molecule known to steer T cell responses is Notch. The Notch pathway is evolutionarily conserved in multi-cellular eukaryotes playing a broad and important role during embryonic development and in adult tissue homeostasis. 24 Notch proteins coordinate cell-cell communication through receptor-ligand (i.e. Delta, Jagged) interactions. Activation cleaves the Notch intracellular domain, which translocates into the nucleus where it binds the transcription factor CSL (CBF1/suppressor of Hairless/Lag-1) in human or RBP-Jκ (recombination signal-binding protein 1 for Jκ) in mice, thereby activating Notch target genes. 25 Notch activity is tightly controlled by proteases that activate (i.e. γ-secretase) Notch receptor signaling. Within the CD4 + T cell lineage Notch can skew T cell responses towards a Th2 phenotype by controlling expression of the lineage specific factor GATA-3. [26] [27] [28] More recently it was demonstrated that Notch can also control T cell proliferation 29 and longevity. 30 Interestingly, NOTCH1 has been described as a substrate of GrB, 31 resulting in loss of its transcriptional activity. 32 Hence, impaired In primary human B cells, IL-21 induced activation of STAT3. 33, 34 Here, we show that IL-21 also activated STAT3 in human primary pDCs leading to increased levels of GrB. Other cytokines, including IL-3 and IL-10, were previously reported to induce expression of GrB in pDCs. 9 As these cytokines act through activation of the JAK/STAT3 as well, it is likely that this is a common pathway for induction of GrB. Interestingly in mice, targeting Stat3 in CD11c + myeloid cells by CpG-siRNA improved key effector functions and proliferation of adoptively transferred T cells. 35 While direct evidence is lacking, it is attractive to consider that this may partially be due to reduced levels of GrB expressed in Stat3 -/-DCs, thereby allowing more extensive T cell proliferation.
PDCs form the first line of defence against viruses and bacteria by rapid production of IFN-α. 36 Conversely, uncontrolled or unwanted pDC-derived production of IFN-α plays a key role in human autoimmune pathogenesis, such as systemic lupus erythematosus (SLE), 37 Sjögren's syndrome (SS), 38 and psoriasis. 39 In addition to IFN-α, also elevated serum levels of IL-21 were detected in patients suffering from SS, SLE, and RA compared to healthy controls. 40, 41 Furthermore, SLE is associated with two single nucleotide polymorphisms of the IL-21 gene. 42 In agreement with these data, elevated IL-21 levels were found in SLE mouse models. 43 While IL-21
is known to enhance anti-CD3 induced proliferation of T cells, 44 it also controls the functional activity of effector T helper (Th) cells, the differentiation of Th17 cells, and counteracts the suppressive effects of regulatory T cells. 45 Moreover, IL-21 either alone or in synergy with BAFF is capable of promoting B cell expansion and plasma B cell differentiation. 44, 46 
